Journal
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
Volume 42, Issue 1, Pages 3-14Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/10409230601146219
Keywords
gamma-aminobutyric acid; benzodiazepines; ligand-gated ion channels; clathrin; gephyrin; GABARAP; Plic-1; endocytosis
Categories
Funding
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047478, R01NS051195, R01NS048045] Funding Source: NIH RePORTER
- NINDS NIH HHS [NS047478, NS048045, NS051195] Funding Source: Medline
- Wellcome Trust Funding Source: Medline
Ask authors/readers for more resources
Fast synaptic inhibition in the brain and spinal cord is mediated largely by ionotropic gamma-aminobutyric acid (GABA) receptors. GABA(A) receptors play a key role in controlling neuronal activity; thus modulating their function will have important consequences for neuronal excitation. GABAA receptors are important therapeutic targets for a range of sedative, anxiolytic, and hypnotic agents and are involved in a number of CNS diseases, including sleep disturbances, anxiety, premenstrual syndrome, alcoholism, muscle spasms, Alzheimer's disease, chronic pain, schizophrenia, bipolar affective disorders, and epilepsy. This review focuses on the functional and pharmacological properties of GABA(A) receptors and trafficking as an essential mechanism underlying the dynamic regulation of synaptic strength.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available